Catalyst Wire Dossier Catalyst Wire Dossier

Vemurafinib

vemurafenib
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vemurafinib, covering 2023-05-31 to 2023-05-31. Get the full timeline:

Most recent: Clinical Trial Update: Study of HL-085 and Vemurafinib in Metastatic Colorectal Cancer (mCRC) [Phase 2]

See pricing